Nipocalimab: all 25 studies that test it
Page 1 of 1. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating WomenRecruitingNCT07669077Phase 1
- A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusRecruitingNCT07438496Phase 3
- Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia GravisRecruitingNCT07217587Phase 3
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingNCT06533098Phase 3
- A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)RecruitingNCT06449651Phase 3
- A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)RecruitingNCT05912517Phase 3
- Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT05327114Phase 2/3
- A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia GravisRecruitingNCT05265273Phase 2/3
- A Study of Nipocalimab Administered to Adults With Generalized Myasthenia GravisRecruitingNCT04951622Phase 3Results posted
- A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid ArthritisCompletedNCT06028438Phase 2Results posted
- A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid ArthritisCompletedNCT04991753Phase 2Results posted
- An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia GravisTerminatedNCT03896295Phase 2Results posted
- A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn (HDFN)CompletedNCT03842189Phase 2Results posted
- A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia GravisCompletedNCT03772587Phase 2Results posted
- Nipocalimab in Moderate to Severe Sjogren's DiseaseActive, not recruitingNCT06741969Phase 3
- A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy ParticipantsCompletedNCT05827874Phase 1
- A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesActive, not recruitingNCT05379634Phase 2
- A Study of JNJ-80202135 in Healthy Chinese Adult ParticipantsCompletedNCT05151692Phase 1
- A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy ParticipantsCompletedNCT04973566Phase 1
- A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)CompletedNCT04968912Phase 2
- A Study of Nipocalimab in Adult Participants With Active Lupus NephritisWithdrawnNCT04883619Phase 2
- A Study of Nipocalimab in Adult Participants With Active Systemic Lupus ErythematosusCompletedNCT04882878Phase 2
- A Study of Nipocalimab in Healthy Male and Female ParticipantsCompletedNCT04848558Phase 1
- Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic AnemiaActive, not recruitingNCT04119050Phase 2/3
- An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)CompletedNCT02828046Phase 1